These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32129453)

  • 1. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population.
    Westra WM; Rygiel AM; Mostafavi N; de Wit GMJ; Roes AL; Moons LMG; Peppelenbosch MP; Ouburg S; Morré SA; Jacobs M; Siersema PD; Repping S; Wang KK; Krishnadath KK
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32129453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
    Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
    Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
    Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
    Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
    Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Barrett's Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis.
    Saha B; Vantanasiri K; Mohan BP; Goyal R; Garg N; Gerberi D; Kisiel JB; Singh S; Iyer PG
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1381-1394.e7. PubMed ID: 37879525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
    Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
    Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
    Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
    Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus.
    Gharahkhani P; Tung J; Hinds D; Mishra A; ; Vaughan TL; Whiteman DC; MacGregor S;
    Hum Mol Genet; 2016 Feb; 25(4):828-35. PubMed ID: 26704365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.